1. A rare case of gastric cancer with bilateral breast metastasis during pregnancy. (January 2021) Authors: Basoglu, Tugba; Telli, Tugba Akin; Demircan, Nazim Can; Arikan, Rukiye; Ercelep, Ozlem; Ozguven, Salih; Soysal, Sunullah; Memisoglu, Asli; Dane, Faysal; Yumuk, Perran Fulden Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 1(2021) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Another adverse effect of vemurafenib: Gingival hyperplasia. Issue 6 (24th December 2015) Authors: Salman, Andac; Tekin, Burak; Koca, Sinan; Akgul Babacan, Nalan; Yumuk, Perran Fulden; Ergun, Tulin Journal: Journal of dermatology Issue: Volume 43:Issue 6(2016) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Issue 3 (June 2021) Authors: Ercelep, Ozlem; Alan, Ozkan; Telli, Tugba A.; Tuylu, Tugba B.; Arıkan, Rukiye; Demircan, Nazim Can; Simsek, Eda T.; Babacan, Nalan A.; Kaya, Serap; Dane, Faysal; Bozkurtlar, Emine; Ones, Tunc; Lacin, Tunc; Yumuk, Perran Fulden Journal: Tumori Issue: Volume 107:Issue 3(2021) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. (9th August 2021) Authors: Bahçeci, Aykut; Paydaş, Semra; Ak, Naziye; Ferhatoğlu, Ferhat; Saip, Pınar Mualla; Seydaoğlu, Gülşah; Bilici, Mehmet; Şimşek, Melih; Tekin, Salim Başol; Çalikuşu, Züleyha; Yavuz, Sinan; Şahin, Ahmet Bilgehan; Çubukçu, Erdem; Evrensel, Türkkan; Değirmencioğlu, Serkan; Demiray, Atike Gökçen; Yumuk,... Journal: Cancer investigation Issue: Volume 39:Number 6/7(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients. (October 2020) Authors: Peled, Nir; Gillis, Roni; Kilickap, Saadettin; Froesch, Patrizia; Orlov, Sergei; Filippova, Elena; Demirci, Umut; Christopoulos, Petros; Cicin, Irfan; Basal, Fatma Bugdayci; Yilmaz, Cengiz; Fedor, Moiseenko; Korkmaz, Taner; Paydas, Semra; Gautschi, Oliver; Zirtiloglu, Alisan; Eralp, Yesim; Cinkir... Journal: Lung cancer Issue: Volume 148(2020) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature. (June 2020) Authors: Alan, Ozkan; Kuzhan, Okan; Koca, Sinan; Telli, Tugba Akin; Basoglu, Tugba; Ercelep, Ozlem; Filinte, Deniz; Sengul, Yildiz; Arikan, Huseyin; Kaya, Serap; Babacan, Nalan Akgul; Dane, Faysal; Yumuk, Perran Fulden Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 4(2020) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma. (30th June 2022) Authors: Telli, Tugba Akin; Bugdayci, Onur; Alan, Ozkan; Sariyar, Nisanur; Isik, Selver; Arikan, Rukiye; Yasar, Alper; Majidova, Nargiz; Celebi, Abdussamet; Erol, Bulent; Ozgen, Zerrin; Kostek, Osman; Bayoglu, Ibrahim Vedat; Ercelep, Ozlem; Dane, Faysal; Yumuk, Perran Fulden Journal: Nutrition and cancer Issue: Volume 74:Number 7(2022) Page Start: 2499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. (7th February 2021) Authors: Demirelli, Bülent; Babacan, Nalan Akgül; Ercelep, Özlem; Öztürk, Mehmet Akif; Kaya, Serap; Tanrıkulu, Eda; Khalil, Süleyman; Hasanov, Rahib; Alan, Özkan; Telli, Tuğba Akın; Koca, Sinan; Arıbal, Mustafa Erkin; Kuzan, Beyza; Dane, Faysal; Yumuk, Perran Fulden Journal: Nutrition and cancer Issue: Volume 73:Number 2(2021) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study. Issue 21 (20th July 2021) Authors: Boyer, Michael; Şendur, Mehmet A. N.; Rodríguez-Abreu, Delvys; Park, Keunchil; Lee, Dae Ho; Çiçin, Irfan; Yumuk, Perran Fulden; Orlandi, Francisco J.; Leal, Ticiana A.; Molinier, Olivier; Soparattanapaisarn, Nopadol; Langleben, Adrian; Califano, Raffaele; Medgyasszay, Balazs; Hsia, Te-Chun; Otter... Journal: Journal of clinical oncology Issue: Volume 39:Issue 21(2021) Page Start: 2327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index. Issue 12 (20th September 2022) Authors: Demirtas, Coskun Ozer; Ricco, Gabrielle; Ozdogan, Osman Cavit; Baltacioglu, Feyyaz; Ones, Tunc; Yumuk, Perran Fulden; Dulundu, Ender; Uzun, Sinan; Colombatto, Pierro; Oliveri, Filippo; Brunetto, Maurizia Rosanna; Gunduz, Feyza Journal: Hepatology communications Issue: Volume 6:Issue 12(2022) Page Start: 3600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗